Psoriasis: all 1,928 studies
Page 2 of 20. Open to participants first (234), then studies with results posted, then the rest; newest registration first within each.
- A Prospective Study to Assess the Efficacy of IL-17 Inhibitors on Subclinical Enthesitis in Patients With Moderate to Severe Psoriasis Based on Power Doppler (PD) Ultrasonography (PDUS)RecruitingNCT06987292
- Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and PsoriasisRecruitingNCT06982352Phase 1
- Sulodexide in Controlling the Recurrence of PsoriasisEnrolling by invitationNCT06982196Phase 3
- A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque PsoriasisRecruitingNCT06979453Phase 3
- Potential Role of Guselkumab in Modulating PAIN Perception and Related Gene Pathways: a Proof-of-concept Study.RecruitingNCT06974474Phase 4
- A Phase III Study of SYHX1901 Tablets in the Treatment of Moderate to Severe Plaque PsoriasisNot yet recruitingNCT06943950Phase 3
- Effect of Semaglutide in Patients With Psoriasis and ObesityRecruitingNCT06937060Phase 3
- A Study to Evaluate Efficacy and Safety of HS-10374 for Mild-to-moderate Plaque PsoriasisNot yet recruitingNCT06926582Phase 2
- To Evaluate the Efficacy and Safety of RSS0393 Ointment in Patients With Plaque Psoriasis Phase II StudyNot yet recruitingNCT06918743Phase 2
- A Study of WD-890 in Participants With Moderate-to-Severe Plaque PsoriasisRecruitingNCT06912165Phase 2
- Effect of Addition of Pyramidal Exercise to Intermittent Fasting on Dryness of Eye in Pre-diabetic Psoriasis PatientsRecruitingNCT06893913Not applicable
- The Efficacy of Topical Formulation Containing Ciplukan (Physalis Angulata Linn.) on Psoriasis Vulgaris LesionsEnrolling by invitationNCT06887322Phase 1/2
- Comparison of Otezla to SFA-002 to Placebo in Plaque Psoriasis PatientsNot yet recruitingNCT06863493Phase 2/3
- A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)RecruitingNCT06857942Phase 4
- Evaluate the Safety and Pharmacokinetics/Pharmacodynamics of HS-20118RecruitingNCT06846710Phase 1
- A Study of HS-20137 in Participants with Moderate-to-severe Plaque PsoriasisNot yet recruitingNCT06844799Phase 3
- Ixekizumab Versus Secukizumab in Over 70-year-old Patients with PsoriasisNot yet recruitingNCT06811558Not applicable
- Real-World Study of Xeligekimab for Moderate to Severe Plaque Psoriasis(XP-Real)Not yet recruitingNCT06802848
- Evaluation of Stigma Toward Patients With Alopecia Areata, Atopic Dermatitis, Vitiligo, and PsoriasisRecruitingNCT06801821
- Efficacy of Injection Sekucinumab in Erythrodermic PsoriasisNot yet recruitingNCT06801028
- A Basket Trial of Vunakizumab in Inflammatory Skin DiseasesNot yet recruitingNCT06794671
- Immune Infiltrate Analysis of Psoriasis Skin During Therapy With Anti-interleukin 23 (IL-23)RecruitingNCT06792487
- Construction of a Psoriasis and Psoriatic Arthritis Diagnostic Model Based on Multidimensional Nail InformationNot yet recruitingNCT06790940
- Early Intervention in Plaque Psoriasis: is Bimekizumab Able to Delay Chronic Inflammation?RecruitingNCT06742333Phase 2
- Assessment of the Effect of a Dermatology-Oriented Spa Therapy on the Quality of Life of Patients With PsoriasisRecruitingNCT06735911Not applicable
- Walk and Talk: Connecting People With PsoriasisRecruitingNCT06726213Not applicable
- Use of a Digital Psychotherapeutic App to Reduce Symptom Burden in Dermatology PatientsRecruitingNCT06702293Not applicable
- A Real-world Study to Evaluate the Effectiveness of Deucravacitinib in Adults With Plaque Psoriasis in France (RePhlect)RecruitingNCT06701513
- Phase IV Study: Vunakizumab Efficacy and Safety in Moderate-to-severe Plaque PsoriasisRecruitingNCT06696417
- A Study to Confirm Efficacy and Safety of HS-10374 for Moderate to Severe Plaque PsoriasisNot yet recruitingNCT06672393Phase 3
- A Phase 3 Study in Moderate-to-Severe Plaque Psoriasis With Piclidenoson to Study Safety and EfficacyNot yet recruitingNCT06643260Phase 3
- A Study to Investigate the Efficacy and Safety Profile of GM-XANTHO [GM-XAN003] in Patients With PsoriasisNot yet recruitingNCT06620692Phase 2
- Characterization of the Fungal Immunopeptidome Involved in the Immunopathological Mechanisms of PsoriasisNot yet recruitingNCT06610942
- Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin DiseasesRecruitingNCT06599411
- HPP737 Substance Balance Study in HumanNot yet recruitingNCT06584058Not applicable
- Multimodal High-frequency Ultrasound-based Study of Plaque Psoriasis Severity IndexNot yet recruitingNCT06579976
- Use of Total-Body PET to Quantify Systemic and Cutaneous Inflammation in Psoriasis Patients Before and After Intervention With a Nutritionally Balanced DietRecruitingNCT06574178Not applicable
- Topical Thymoquinone in Psoriasis VulgarisNot yet recruitingNCT06508372Not applicable
- Cream Containing Sericin and Turmeric in Psoriasis PatientsNot yet recruitingNCT06482398Not applicable
- Long-Term Safety and Efficacy of HB0034 in Subjects With Generalized Pustular PsoriasisRecruitingNCT06477536Phase 2/3
- Analytical Validation of Wrist-Based Assessment of Nocturnal Scratch in Atopic Dermatitis and PsoriasisRecruitingNCT06448689
- Low-Dose Enoxaparin in PsoriasisNot yet recruitingNCT06416566Not applicable
- PSODEEP2 Pilot Study on Koebner Induction in PsoriasisNot yet recruitingNCT06414382Not applicable
- Comprehensive Intervention of Diabetes and Psoriasis Comorbidity Prevention and ControlNot yet recruitingNCT06402760Early Phase 1
- Mediterranean Diet vs no Dietary Intervention for Improving Signs and Symptoms of Psoriasis in Patients Treated With Anti-IL-17 or Anti-IL-23 InhibitorsRecruitingNCT06399432Not applicable
- A Multicentre Randomized Controlled Clinical Study on the Chitosan Nanocrystalline Qinteng Huoxue Runji Ointment Therapy for Psoriasis With Blood Stasis Syndrome.Not yet recruitingNCT06396013Phase 1
- Clinico-biological Collection of Autoimmune, Dysimmune or Auto-inflammatory Dermatological DiseasesRecruitingNCT06387654
- A Study of the Comparative Effectiveness of Deucravacitinib in Adults With Plaque Psoriasis in Japan (RePhlect)RecruitingNCT06382987
- Modifying PEST for Psoriatic Arthritis ScreeningRecruitingNCT06382051Not applicable
- To Evaluate the Pharmacokinetics of Hemay005 Tablets in Subjects With Liver DamageRecruitingNCT06376474Phase 1
- Efficacy and Safety of Ixekizumab in Patients with Refractory Guttate PsoriasisNot yet recruitingNCT06374979Phase 2/3
- Evaluation of TWEAK in Plaque Psoriasis and Psoriatic Arthritis PatientsNot yet recruitingNCT06370156
- Understanding Participation Habits Among Plaque Psoriasis PatientsNot yet recruitingNCT06338358
- A Pilot Cohort Study of Risk Factors and Novel Methods of Skin Lesion Assessments in Adults With Atopic Dermatitis, Alopecia Areata, Psoriasis or VitiligoRecruitingNCT06319781
- An Phase III Study of Recombinant Anti-IL-17A Humanized Monoclonal Antibody in Chinese Participants With PsONot yet recruitingNCT06299982Phase 3
- Effect of Silymarin Against Methotrexate-induced Liver Injury in Rheumatic DiseasesRecruitingNCT06277635Not applicable
- Real-World Safety and Effectiveness of Sotyktu (Deucravacitinib) in Patients With Moderate-to-Severe Plaque Psoriasis in KoreaRecruitingNCT06258668
- Efficacy and Safety of HB0034 in Patients with Generalized Pustular Psoriasis (GPP)RecruitingNCT06231381Phase 2
- Involvement of Pollutants in Atopic Dermatitis and PsoriasisNot yet recruitingNCT06213688Not applicable
- Botox Versus Tacrolimus in Psoriasis VulgarisNot yet recruitingNCT06203470Phase 4
- A Study of QY101 Ointment in Subjects With Plaque PsoriasisRecruitingNCT06170840Phase 2
- The Relationship Between Moderate-to-severe Psoriasis and Sleep DisturbanceNot yet recruitingNCT06165887
- Methotrexate Alone vs Combination With Excimer Light in Nail PsoriasisNot yet recruitingNCT06150794Not applicable
- A Study to Evaluate the Efficacy and Safety of LZM012RecruitingNCT06110676Phase 3
- A Study to Evaluate Efficacy and Safety of HS-10374 for Moderate to Severe Plaque PsoriasisRecruitingNCT06077331Phase 2
- Efficacy and Safety of Jiuweihuaban Pill for Treating Plaque PsoriasisRecruitingNCT06058546Phase 2
- Association Between the Occurrence of a Clinical RElapse and Gut MIcrobiota Modifications: a Cohort Study of Patients With pSOriasisNot yet recruitingNCT06055699
- A Study to Assess the Effects of Switching From a Biologic Treatment to Tildrakizumab Using Patient-reported Outcomes in Adult Participants With Moderate to Severe Plaque PsoriasisRecruitingNCT06030076
- A Study of Tildrakizumab in the Treatment of Genital Psoriasis (CZATCH-Genital-PsO)RecruitingNCT06029257
- Study Evaluation of the Efficacy, Safety and Immunogenicity of Adalimumab in Comparison With Humira®RecruitingNCT06005532Phase 3
- Collection of Samples From Subjects With Various Skin Conditions and Healthy VolunteersRecruitingNCT05994976
- Psoriasis and Non Alcoholic Steatohepatitis: Is There a Shared Inflammatory Network ?Not yet recruitingNCT05994677
- COVID-19 Associated With PsoriasisRecruitingNCT05961605
- Association Between Biologic Therapy and Demodex Density in Psoriasis Patients: A Comparative StudyRecruitingNCT05954572
- Determinants of Chronic Inflammatory Skin Disease TrajectoriesRecruitingNCT05928169
- Using Acetylcysteine and Vitamin E With Psoriasis VulgarisRecruitingNCT05906498Phase 3
- Low-Salt Diet Effect on Th17-Mediated Inflammation and Vascular Reactivity in PsoriasisRecruitingNCT05892640Not applicable
- Effect of Adalimumab Therapy on Psoriasis PatientNot yet recruitingNCT05889338Not applicable
- IMPACT - AndHealth Autoimmune Research RegistryRecruitingNCT05883371
- HIPPOCRATES Prospective Observational StudyRecruitingNCT05858528
- A Real-world Observational Study to Compare Effectiveness of Deucravacitinib Vs Apremilast in Adults With Plaque PsoriasisRecruitingNCT05744466
- Quantitative Fluorescence Molecular Imaging of Ustekinumab-800CW to Elucidate the Drug Distribution Throughout Inflamed Tissue in Crohn's Disease and Psoriasis.RecruitingNCT05725876Phase 1
- Therapeutic Drug Monitoring of Risankizumab in Psoriasis Patients (BIOLOPTIM-RIS)RecruitingNCT05685940Phase 4
- Therapeutic Drug Monitoring of Tildrakizumab in Psoriasis PatientsRecruitingNCT05683015Phase 4
- Dietary Approach to Mild-to-moderate PsoriasisRecruitingNCT05644782Not applicable
- Study of SFA002 in Patients with Mild to Moderate Psoriasis PlaquesRecruitingNCT05642182Phase 1
- UVB-induced Treg Cells Exert Antigen-specific Suppression Through LAG-3RecruitingNCT05636839Not applicable
- Immunoclassification of Psoriasis: a Strategy for Precision MedicineRecruitingNCT05503875Not applicable
- Meditation in Inflammatory DermatosisRecruitingNCT05500794Not applicable
- Value Based Healthcare in PsoriasisRecruitingNCT05480917Not applicable
- Role of Glucose Metabolism in Migration of Cutaneous Dendritic Cells in PsoriasisRecruitingNCT05399433Not applicable
- Cytokine Expression in Psoriasis Patients With and Without Joint InvolvementRecruitingNCT05307809Not applicable
- Development of Predictive Psoriasis Response Endotypes Using Single Cell TranscriptomicsRecruitingNCT05270733Phase 4
- Augmenting Standard-of-care Treatment of Plaque Psoriasis by NeuromodulationRecruitingNCT05243303Not applicable
- The Effect of Dietary Intervention on Endothelial Glycocalyx in PsoriasisRecruitingNCT05184699Not applicable
- ProspectIve Cohort psoriASiS fOllow-up (PICASSO)RecruitingNCT05122039
- Exploration of the Cellular and Molecular Mechanisms in Patients Receiving Biotherapies Targeting the IL-23/IL-17 Axis in Cutaneous PsoriasisRecruitingNCT05111210
- A Prospective, Observational Study of Clinician and Patient-reported Outcomes in Patients With Dermatological ConditionsEnrolling by invitationNCT05084417
- Multi-Center PAMPA StudyRecruitingNCT05004727Phase 4
- Prevalence and Risk Factors asSOciated With CArdiac comorbiDIty in psoriAsisRecruitingNCT04950218